Obermatt
See Similar Stocks →

DaVita

NYQ:DVA · US23918K1088
Health Care Providers & ServicesX-Large

360

40
EV / EBIT65
Price / Owner Earnings52
Owner Earnings Yield68
Dividend Yield1
Price/Sales48
EV / Gross Profit45
Price/Book1
Return on Capital82
Cash Return on Capital61
Return on Equity98
EBIT Margin91
Gross Profitability49
Cash Conversion59
Accruals57
Owner Earnings Margin76
Sales growth31
Profit Growth79
Long-Term EPS Growth68
Owner Earnings Growth42
Reinvestment29
Price momentum76
Debt load16
Refinancing77
Debt Payback22
Liquidity62
Analyst ratings7
Opinion Changes65
Price Target Upside16
Market mood41
Value Creation12/20creating some value
  • Creates more value than its capital costs
  • Owner earnings growing
  • Owner earnings per share growing
  • Reinvests at strong returns
  • Solid earnings base

What this means

DaVita clears its cost of capital, but the record is mixed across the five tests. Real value creation, just not yet consistent.

Profile

CountryUSA
IndustryHealth Care Providers & Services
SizeX-Large
TypePublic Company
ExchangeNYSE
Founded1994
Employees23,075
Websitedavita.com
ISINUS23918K1088
Last UpdateApr 2, 2026
Indices
S&P 500 (USA)D.J. US Health Care
Themes
Health DiagnosticsNephrologyOutpatient CareChronic DiseasesHealth Care

Description

DaVita Inc. (‘DaVita’), together with its subsidiaries, provides healthcare which focuses on transforming care delivery to improve quality of life for patients globally. As a comprehensive kidney care provider, the company has been a leader in clini…

Analysis

Quality compounder

DaVita Inc. earns the quality_compounder label: good underlying economics priced fairly, with no obvious bargain or excess.

On valuation, the picture is attractive. The owner-earnings multiple stands at 13.5×; owner earnings: the cash an owner could take out each year. The implied growth embedded in that price is around 1% a year, against analyst forecasts of 26%. The price, in other words, assumes less than the experts do.

Growth is moderate; the safety picture is stretched. The company scores 12/20 on our value-creation score: creating some value. Analyst sentiment is cautious.

Flags to be aware of: The financial cushion is thinner than comfortable. A large part of the company's book value is the price paid for past acquisitions. As always: this describes the company's numbers; it is not a recommendation.

360° rank · history

1007550250
23
2023202420252026

All-time high

69

Jan 2026

All-time low

10

Nov 2024

Average rank

39

across all years

Detailed & Historical Ranks

Deep dive into 15 detailed ranks and 3 years of history.

Current202520242023
Price/Sales
48
53
54
66
Price/Earnings
64
66
88
71
Price/Book
1
1
6
11
Dividend Yield
1
1
1
1
Value (overall)
20
82
17
33

Cells are coloured by rank band (red weak → green strong). Sentiment & 360° history begins 2023.

Similar Stocks

The companies this stock is ranked against.

Compare DaVita with its peers
OPKO Health
NSQ:OPK
8
CountryUSA
IndustryHealth Care Providers & Services
SizeMedium
Full Stock Analysis →
Acadia Healthcare
NSQ:ACHC
23
CountryUSA
IndustryHealth Care Providers & Services
SizeMedium
Full Stock Analysis →
Astrana Health
NAQ:ASTH
62
CountryUSA
IndustryHealth Care Providers & Services
SizeMedium
Full Stock Analysis →
McKesson
NYQ:MCK
83
CountryUSA
IndustryHealth Care Providers & Services
SizeX-Large
Full Stock Analysis →
AdaptHealth
NAQ:AHCO
49
CountryUSA
IndustryHealth Care Providers & Services
SizeLarge
Full Stock Analysis →
Tactile Systems Technology
NMQ:TCMD
98
CountryUSA
IndustryHealth Care Equipment & Supplies
SizeMedium
Full Stock Analysis →

Make Sense of the Ranks

Every rank runs 1–100 against true peers. Higher is always better.

360° View
1 · Watch OutGood· 100
Value
1 · ExpensiveGood Value· 100
Quality
1 · Weak FundamentalsHigh Quality· 100
Growth
1 · Tough TimesHigh Growth· 100
Safety
1 · High LeverageWell-Financed· 100
Sentiment
1 · SkepticismPositive· 100
Learn More →